Kristina Burow
Vermögen: 6 Mio $ am 31.05.2026
Vermögen: 6 Mio $ am 31.05.2026
Ms. Kristina M.
Burow is an Independent Director at Neumora Therapeutics, Inc., an Independent Director at Boundless Bio, Inc., an Independent Director at Scholar Rock Holding Corp., a Managing Director at ARCH Venture Partners LP and a Managing Director at ARCH Venture Partners LLC.
She is on the Board of Directors at Neumora Therapeutics, Inc., Autobahn Therapeutics, Inc., Boundless Bio, Inc., Scholar Rock, Inc., Scholar Rock Holding Corp., Architect Therapeutics, Inc., Asteroid Therapeutics, Inc., Magnet Biomedicine, Inc., Mirador Therapeutics, Inc., National Venture Capital Association, Orbital Therapeutics, Inc., Pretzel Therapeutics, Inc., Rome Therapeutics, Inc., Treeline Biosciences, Inc. and Trelys, Inc. Ms. Burow was previously employed as an Independent Director by Gossamer Bio, Inc., an Independent Director by Beam Therapeutics, Inc., an Independent Director by Vir Biotechnology, Inc., an Independent Director by Sienna Biopharmaceuticals, Inc., an Independent Director by Metacrine, Inc., an Independent Director by Unity Biotechnology, Inc., an Independent Director by Receptos, Inc., an Associate by Novartis Bioventure Fund, a Principal by Novartis Institute for Functional Genomics, Inc., and an Associate by Novartis Venture.
She also served on the board at Metsera, Inc., Vividion Therapeutics, Inc., BlackThorn Therapeutics, Inc., AgBiome LLC, Lycera Corp., Sapphire Energy, Inc., AgTech Accelerator Corp., Celgene Corp., Epirium Bio, Inc., Kilimanjaro Energy, Inc., LearnZillion, Inc., Limerick BioPharma, Inc. and Reactive Biosciences, Inc. She received her undergraduate degree from the University of California, Berkeley, a graduate degree from The Trustees of Columbia University in The City of New York, a graduate degree from Columbia University College of Pharmaceutical Sciences and an MBA from The University of Chicago Booth School of Business.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 04.06.2026 | 117 710 ( 0,1 % ) | 6 Mio $ | 31.05.2026 | |
| 27.05.2026 | 47 717 ( 0,03 % ) | 88 276 $ | 31.05.2026 | |
BOUNDLESS BIO INC. -.--% | 20.04.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Direktor/Vorstandsmitglied | 01.08.2014 |
| BOUNDLESS BIO, INC. | Direktor/Vorstandsmitglied | 01.02.2018 |
| NEUMORA THERAPEUTICS, INC. | Gründer | 01.01.2020 |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Private Equity Investor | 01.01.2002 |
ARCH Venture Partners LP
ARCH Venture Partners LP Investment ManagersFinance Operates as venture capital firm | Corporate Officer/Principal | 01.11.2011 |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for cancer and autoimmune diseases | Direktor/Vorstandsmitglied | - |
Autobahn Therapeutics, Inc.
Autobahn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops medications for the treatment of central nervous system (CNS) disorders | Direktor/Vorstandsmitglied | 01.02.2018 |
Treeline Biosciences, Inc.
Treeline Biosciences, Inc. BiotechnologyHealth Technology Develops molecule inhibitors, protein degraders and targeted therapy antibody-drug conjugates for cancer, autoimmune and neurological diseases | Direktor/Vorstandsmitglied | - |
National Venture Capital Association
National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services Provides business association services | Direktor/Vorstandsmitglied | - |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 40 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
ARCH Venture Partners LP
ARCH Venture Partners LP Investment ManagersFinance Operates as venture capital firm | Finance |
Lycera Corp.
Lycera Corp. Pharmaceuticals: MajorHealth Technology Develops novel oral medicines for treating autoimmune diseases and cancer | Health Technology |
Sapphire Energy, Inc.
Sapphire Energy, Inc. Oil & Gas ProductionEnergy Minerals Develops and produces algae-based crude oil | Energy Minerals |
Receptos LLC
Receptos LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapeutics in immune disease | Health Technology |
Kilimanjaro Energy, Inc.
Kilimanjaro Energy, Inc. Industrial MachineryProducer Manufacturing Develops advanced technologies to capture atmospheric carbon-dioxides | Producer Manufacturing |
Epirium Bio, Inc.
Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems | Health Technology |
LearnZillion, Inc.
LearnZillion, Inc. Miscellaneous Commercial ServicesCommercial Services Develops a web-based education tool and video library of math and literacy lessons | Commercial Services |
Trelys, Inc.
Trelys, Inc. Chemicals: SpecialtyProcess Industries Manufactures hydrogen and carbon dioxide products | Process Industries |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Bioventure Fund
Novartis Bioventure Fund Investment ManagersFinance Acts as Venture Capital Fund | Finance |
National Venture Capital Association
National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services Provides business association services | Commercial Services |
Limerick BioPharma, Inc.
Limerick BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Novartis Institute for Functional Genomics, Inc.
Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts research related to biotechnology and medicine | Commercial Services |
The University of Chicago Booth School of Business
The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AgBiome INC
AgBiome INC BiotechnologyHealth Technology Operates as a biotechnology platform that develops isolated microbes for agriculture industry | Health Technology |
BlackThorn Therapeutics, Inc.
BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for neuron developmental disorders | Health Technology |
Metacrine, Inc.
Metacrine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in discovery and development of therapies for patients with liver and gastrointestinal diseases | Health Technology |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Unity Biotechnology, Inc.
Unity Biotechnology, Inc. BiotechnologyHealth Technology Engages in the research and development of therapeutics to extend the human healthspan | Health Technology |
Sienna Biopharmaceuticals, Inc.
Sienna Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and manufactures drugs for treating inflammatory skin disorders | Health Technology |
Vividion Therapeutics, Inc.
Vividion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology research company which develops precision therapeutics for cancers and immune disorders | Health Technology |
AgTech Accelerator Corp.
AgTech Accelerator Corp. Financial ConglomeratesFinance Provides financial services for agriculture companies | Finance |
Vir Biotechnology, Inc.
Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Reactive Biosciences, Inc.
Reactive Biosciences, Inc. BiotechnologyHealth Technology Operates as small molecule development company which focuses on leveraging chemical properties for crop protection and animal health | Health Technology |
Columbia University College of Pharmaceutical Sciences
Columbia University College of Pharmaceutical Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gossamer Bio, Inc.
Gossamer Bio, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing therapeutics for immunology, inflammation and oncology diseases | Health Technology |
Scholar Rock Holding Corp.
Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
Beam Therapeutics, Inc.
Beam Therapeutics, Inc. BiotechnologyHealth Technology Operate as a biotechnology company that develops precision genetic medicines, gene editing and delivery technologies | Health Technology |
Boundless Bio, Inc.
Boundless Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that develops cancer therapeutics | Health Technology |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for cancer and autoimmune diseases | Health Technology |
Autobahn Therapeutics, Inc.
Autobahn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops medications for the treatment of central nervous system (CNS) disorders | Health Technology |
Treeline Biosciences, Inc.
Treeline Biosciences, Inc. BiotechnologyHealth Technology Develops molecule inhibitors, protein degraders and targeted therapy antibody-drug conjugates for cancer, autoimmune and neurological diseases | Health Technology |
Asteroid Therapeutics, Inc.
Asteroid Therapeutics, Inc. BiotechnologyHealth Technology Operates as a bio technology business | Health Technology |
Neumora Therapeutics, Inc.
Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
Pretzel Therapeutics, Inc.
Pretzel Therapeutics, Inc. BiotechnologyHealth Technology Provides mitochondrial biology solutions | Health Technology |
Magnet Biomedicine, Inc.
Magnet Biomedicine, Inc. Miscellaneous Commercial ServicesCommercial Services Develops modular platform which enables the systematic discovery of true molecular glues towards the treatment of human disease | Commercial Services |
Orbital Therapeutics, Inc.
Orbital Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA-based medicines | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen